BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year ...

LEO Pharma will acquire the global product rights, except for Afghanistan and Pakistan, and take over the sales and marketing teams in 14 countries, as well as Bayer’s Italian factory in Segrate.